Fabtech Technologies - Fablife
Divulging Technology Globally  Vaccines . Biotherapeutics . Sera Divulging Technology Globally  Vaccines . Biotherapeutics . Sera Divulging Technology Globally  Vaccines . Biotherapeutics . Sera
About Us
Process Development
Technology Transfer
Careers
Contact Us
Products
Technology Transfer

Conjugate Vaccine:

A conjugate vaccine is created by covalently attaching a poor (polysaccharide organism) antigen to a carrier protein (preferably from the same microorganism), thereby conferring the immunological attributes of the carrier on the attached antigen. This technique for the creation of an effective immunogen is most often applied to bacterial polysaccharides for the prevention of invasive bacterial disease.

Fablife offer and provide technology for manufacturing Conjugate Vaccines like Hib, Mening and Pneumococcal under polysaccharide conjugate vaccine group.

  • Human vaccines: Tetanus, DPT- Diphtheria, Pertussis, Tetanus, pneumococcal (selected serotypes), Meningitis, Haemophilus influenza B, Hepatitis B, Human papilloma virus vaccine (HPV16, 18), acellular Pertussis and Pentavalent vaccine.
  • Bio similars: Recombinant human Erythropoietin (rhEPO), Granulocyte stimulating factor (GCSF), Interferon's(IFN)
  • MABs: CHO cell based Etanercept, Trastuzumab and Rituximab.

Bacterial Toxins: Fablife expertise develops Bacterial toxin group of Vaccine viz,

Exotoxin : Tetanus, Diphtheria group,

Endotxin: Pertussis

Recombinant Vaccines: Engineered viruses or bacteria into which harmless genetic material and other disease-causing organisms are inserted. Employing delivery agents called vectors, recombinant vaccines aim to create a strong antibody and T-cell immune response leading to protection against the targeted disease.

Fablife develops Recombinant protein or peptides vaccine (HBsAg vaccine,) by using Pichia pastoris

Welcome to Fablife